Svendsen P - Search Results

1

miR-155 as a Biomarker in B-Cell Malignancies.

Due H, Svendsen P, Bødker JS, Schmitz A, Bøgsted M, Johnsen HE, El-Galaly TC, Roug AS, Dybkær K. Due H, et al. Among authors: svendsen p. Biomed Res Int. 2016;2016:9513037. doi: 10.1155/2016/9513037. Epub 2016 May 16. Biomed Res Int. 2016. PMID: 27294145 Free PMC article. Review.

2

The application of human phase 0 microdosing trials: A systematic review and perspectives.

Svendsen P, El-Galaly TC, Dybkær K, Bøgsted M, Laursen MB, Schmitz A, Jensen P, Johnsen HE. Svendsen P, et al. Leuk Lymphoma. 2016;57(6):1281-90. doi: 10.3109/10428194.2015.1101097. Epub 2015 Nov 16. Leuk Lymphoma. 2016. PMID: 26428262 Review.

3

R-CHOP(-like) treatment of diffuse large B-cell lymphoma significantly reduces CT-assessed vertebral bone density: a single center study of 111 patients.

Svendsen P, Shekhrajka N, Nielsen KL, Vestergaard P, Poulsen MØ, Vistisen AK, Munksgaard PS, Severinsen MT, Jensen P, Johnsen HE, Jakobsen LH, Bøgsted M, Frøkjær JB, El-Galaly TC. Svendsen P, et al. Leuk Lymphoma. 2017 May;58(5):1105-1113. doi: 10.1080/10428194.2016.1233543. Epub 2016 Oct 13. Leuk Lymphoma. 2017. PMID: 27736260

4

Bone mass density in lean and overweight women with polycystic ovary syndrome.

Mørch NF, Aziz M, Svendsen PF. Mørch NF, et al. Among authors: svendsen pf. Scand J Clin Lab Invest. 2022 May;82(3):210-217. doi: 10.1080/00365513.2022.2049359. Epub 2022 Mar 18. Scand J Clin Lab Invest. 2022. PMID: 35301939

5

[Polycystic ovary syndrome. New pathophysiological discoveries--therapeutic consequences].

Svendsen PF, Nilas L, Nørgaard K, Madsbad S. Svendsen PF, et al. Ugeskr Laeger. 2005 Aug 22;167(34):3147-51. Ugeskr Laeger. 2005. PMID: 16117910 Review. Danish.

6

Obesity, body composition and metabolic disturbances in polycystic ovary syndrome.

Svendsen PF, Nilas L, Nørgaard K, Jensen JE, Madsbad S. Svendsen PF, et al. Hum Reprod. 2008 Sep;23(9):2113-21. doi: 10.1093/humrep/den211. Epub 2008 Jun 12. Hum Reprod. 2008. PMID: 18556679

7

Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.

Svendsen PF, Nilas L, Madsbad S, Holst JJ. Svendsen PF, et al. Metabolism. 2009 May;58(5):586-93. doi: 10.1016/j.metabol.2008.11.009. Metabolism. 2009. PMID: 19375579

8

The insulin-resistant phenotype of polycystic ovary syndrome.

Svendsen PF, Madsbad S, Nilas L. Svendsen PF, et al. Fertil Steril. 2010 Aug;94(3):1052-8. doi: 10.1016/j.fertnstert.2009.04.008. Epub 2009 Jul 5. Fertil Steril. 2010. PMID: 19580964

9

Expression of 11beta-hydroxysteroid dehydrogenase 1 and 2 in subcutaneous adipose tissue of lean and obese women with and without polycystic ovary syndrome.

Svendsen PF, Madsbad S, Nilas L, Paulsen SK, Pedersen SB. Svendsen PF, et al. Int J Obes (Lond). 2009 Nov;33(11):1249-56. doi: 10.1038/ijo.2009.165. Epub 2009 Aug 25. Int J Obes (Lond). 2009. PMID: 19704410

10

Skeletal muscle mitochondrial function in polycystic ovarian syndrome.

Rabøl R, Svendsen PF, Skovbro M, Boushel R, Schjerling P, Nilas L, Madsbad S, Dela F. Rabøl R, et al. Among authors: svendsen pf. Eur J Endocrinol. 2011 Oct;165(4):631-7. doi: 10.1530/EJE-11-0419. Epub 2011 Jul 28. Eur J Endocrinol. 2011. PMID: 21798960

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

273 results

Search Page